Clinical Trial Update: Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating how cannabis potency affects brain white matter in individuals with early psychosis; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis

Drugs mentioned

• Cannabis (Cannabis)

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Psychosis, Cannabis Use | Phase 4 | Status: RECRUITING